Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Evofem Biosciences, Inc. (EVFM)

OID · Biotechnology

$0.01+0.00 (+13.70%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$1.1M
P/E (TTM)
EPS
$-0.05
Div Yield
52W Range
$0.00–$0.02
Beta
-1.32

Company overview

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

29 employeeswww.evofem.com

Peers in Healthcare

Evofem Biosciences, Inc. has no peer companies in this window.

Recent press releases

Evofem Biosciences, Inc. has not issued a press release in this window.

SEC filings

All filings →

Evofem Biosciences, Inc. has not filed an SEC document in this window.

Evofem Biosciences, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2024-09-30

People at Evofem Biosciences, Inc.

All people →

No officers or directors have been indexed for Evofem Biosciences, Inc..

Quarterly financials

Full financials →
Revenue trend
03/25
$845.0K
NI $956.0K
06/25
$4.8M
NI -$1.8M
09/25
$5.0M
NI -$1.6M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.01
Prior: $-0.02
Revenue sparkline
EVFM (OID) Stock Quote, Press Releases & SEC... | Cayman Journal | Cayman Journal